Variability in absorption of insulin-I 131 in normal and diabetic subjects after subcutaneous and intramuscular injection.
作者信息
MOORE E W, MITCHELL M L, CHALMERS T C
出版信息
J Clin Invest. 1959 Jul;38(7):1222-7. doi: 10.1172/JCI103897.
Abstract
摘要
相似文献
1
Variability in absorption of insulin-I 131 in normal and diabetic subjects after subcutaneous and intramuscular injection.正常人和糖尿病患者皮下及肌肉注射胰岛素-I 131后的吸收变异性。
J Clin Invest. 1959 Jul;38(7):1222-7. doi: 10.1172/JCI103897.
2
Effects of accidental intramuscular injection on insulin absorption in IDDM.意外肌肉注射对胰岛素依赖型糖尿病患者胰岛素吸收的影响。
Diabetes Care. 1988 Jan;11(1):41-5. doi: 10.2337/diacare.11.1.41.
3
Feasibility study of vertical subcutaneous injection of insulin with an insulin pen injector in diabetic patients with normal body mass index.
J Int Med Res. 2010 Mar-Apr;38(2):669-73. doi: 10.1177/147323001003800230.
4
Comparison of the effectiveness of various routes of insulin injection: insulin levels and glucose response in normal subjects.不同胰岛素注射途径的有效性比较：正常受试者的胰岛素水平及血糖反应
J Clin Endocrinol Metab. 1976 May;42(5):869-74. doi: 10.1210/jcem-42-5-869.
5
An angled insertion technique using 6-mm needles markedly reduces the risk of intramuscular injections in children and adolescents.使用6毫米针头的斜角进针技术显著降低了儿童和青少年肌肉注射的风险。
Diabet Med. 2007 Dec;24(12):1400-5. doi: 10.1111/j.1464-5491.2007.02272.x.
6
Glucose-lowering effect of insulin by different routes in obese and lean nonketotic diabetic patients.胰岛素不同给药途径对肥胖和非肥胖非酮症糖尿病患者的降糖作用
J Clin Endocrinol Metab. 1978 Jul;47(1):34-40. doi: 10.1210/jcem-47-1-34.
7
Management of diabetic crisis by small doses of intramuscular insulin.小剂量肌肉注射胰岛素治疗糖尿病危象
J Med Assoc Thai. 1980 Jan;63(1):28-34.
8
Variability of insulin absorption and insulin action.胰岛素吸收与胰岛素作用的变异性。
Diabetes Technol Ther. 2002;4(5):673-82. doi: 10.1089/152091502320798312.
9
Diabetic ketoacidosis: low-dose insulin therapy by various routes.糖尿病酮症酸中毒：不同途径的小剂量胰岛素治疗
N Engl J Med. 1977 Aug 4;297(5):238-41. doi: 10.1056/NEJM197708042970502.
10
A 4-mm needle reduces the risk of intramuscular injections without increasing backflow to skin surface in lean diabetic children and adults.对于体型偏瘦的糖尿病儿童和成人，使用4毫米的针头可降低肌肉注射的风险，且不会增加回流至皮肤表面的情况。
Diabetes Care. 2008 Sep;31(9):e65. doi: 10.2337/dc08-0977.
引用本文的文献
1
Influence of metabolic state and body composition on the action of pharmacological treatment of migraine.代谢状态和身体成分对偏头痛药物治疗作用的影响。
J Headache Pain. 2024 Feb 13;25(1):20. doi: 10.1186/s10194-024-01724-3.
2
Effect of diabetes mellitus on pharmacokinetic and pharmacodynamic properties of drugs.糖尿病对药物的药代动力学和药效学特性的影响。
Clin Pharmacokinet. 2012 Aug 1;51(8):481-99. doi: 10.2165/11631900-000000000-00000.
3
Studies on human growth hormone. II. The physiological disposition and metabolic fate of human growth hormone in man.人类生长激素研究。II. 人类生长激素在人体内的生理分布及代谢命运。
J Clin Invest. 1962 Feb;41(2):262-8. doi: 10.1172/JCI104479.
4
[New observations on the treatment of chronic insulin resistance and experimental research on its genesis].慢性胰岛素抵抗治疗的新观察及其发病机制的实验研究
Klin Wochenschr. 1963 Mar 15;41:257-64. doi: 10.1007/BF01483389.
5
Matched glucose responses to insulin administered subcutaneously and intravenously. Evidence for subcutaneous inactivation of insulin.皮下注射和静脉注射胰岛素后的匹配葡萄糖反应。胰岛素皮下失活的证据。
Diabetologia. 1980 May;18(5):423-6. doi: 10.1007/BF00276825.
6
Pharmacokinetic approach for reconstruction of predetermined plasma insulin profiles by continuous subcutaneous insulin infusion in depancreatized dogs.通过对胰腺切除犬进行持续皮下胰岛素输注来重建预定血浆胰岛素曲线的药代动力学方法。
J Pharmacokinet Biopharm. 1983 Dec;11(6):595-609. doi: 10.1007/BF01059059.
7
[Chronic insulin resistance].[慢性胰岛素抵抗]
Acta Diabetol Lat. 1970 Mar-Apr;7(2):220-42. doi: 10.1007/BF01556784.
8
Modeling absorption kinetics of subcutaneous injected soluble insulin.
J Pharmacokinet Biopharm. 1989 Feb;17(1):67-87. doi: 10.1007/BF01059088.
9
NovoSol Basal: pharmacokinetics of a novel soluble long acting insulin analogue.诺和佳基础胰岛素：一种新型可溶性长效胰岛素类似物的药代动力学
BMJ. 1989 Aug 12;299(6696):415-9. doi: 10.1136/bmj.299.6696.415.
10
The effects of diabetes mellitus on pharmacokinetics and pharmacodynamics in humans.糖尿病对人体药代动力学和药效学的影响。
Clin Pharmacokinet. 1991 Jun;20(6):477-90. doi: 10.2165/00003088-199120060-00004.
本文引用的文献
1
The role of nonprecipitating insulin antibodies in diabetes.非沉淀性胰岛素抗体在糖尿病中的作用。
J Clin Invest. 1958 Jun;37(6):787-93. doi: 10.1172/JCI103665.
2
Nonprecipitating insulin antibodies.非沉淀性胰岛素抗体
J Clin Invest. 1958 Jun;37(6):783-6. doi: 10.1172/JCI103664.
3
A comparison of the behavior of insulin and insulin labeled with I 131 in serum.胰岛素与用I 131标记的胰岛素在血清中的行为比较。
Diabetes. 1958 Jan-Feb;7(1):38-45. doi: 10.2337/diab.7.1.38.
4
Studies on insulin labeled with I 131.关于用碘131标记胰岛素的研究。
Ann N Y Acad Sci. 1957 Aug 30;70(1):94-108. doi: 10.1111/j.1749-6632.1957.tb35381.x.
5
Studies with insulin-binding antibody.胰岛素结合抗体研究。
Diabetes. 1957 Sep-Oct;6(5):402-5 discussion 405-7. doi: 10.2337/diab.6.5.402.
6
Apparent inhibition of liver insulinase activity by serum and serum fractions containing insulin-binding antibody.含胰岛素结合抗体的血清及血清组分对肝脏胰岛素酶活性的明显抑制作用。
J Clin Invest. 1957 May;36(5):648-55. doi: 10.1172/JCI103465.
7
Ethanol fractionation of plasma and electrophoretic identification of insulin-binding antibody.血浆的乙醇分级分离及胰岛素结合抗体的电泳鉴定
J Clin Invest. 1957 May;36(5):642-7. doi: 10.1172/JCI103464.
8
Physical binding of insulin by gamma globulins of insulin-resistant subjects.胰岛素抵抗受试者的γ球蛋白对胰岛素的物理结合作用。
J Clin Invest. 1957 Mar;36(3):393-7. doi: 10.1172/JCI103435.
9
Insulin I-131 metabolism in man; plasma-binding, distribution and degradation.人体内胰岛素I-131的代谢；血浆结合、分布及降解
Am J Med. 1956 Sep;21(3):324-38. doi: 10.1016/0002-9343(56)90034-1.
10
The distribution and metabolism of insulin labeled with radioactive iodine (I131) in normal and diabetic subjects.放射性碘（I131）标记的胰岛素在正常人和糖尿病患者体内的分布与代谢。
Diabetes. 1956 Jan-Feb;5(1):15-7. doi: 10.2337/diab.5.1.15.
Zotero 插件